Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes

Kidney International

Volumn 69, Issue 3, 2006, Pages 616-620

  Nasr, S H ^a   Preddie, D C ^a   Markowitz, G S ^a   Appel, G B ^a   D'Agati, V D ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; IMMUNOGLOBULIN G; PAMIDRONIC ACID; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENERAL CONDITION IMPROVEMENT; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; LABORATORY TEST; LEG EDEMA; MEDICAL EXAMINATION; MULTIPLE MYELOMA; NEPHROTIC SYNDROME; OSTEOPENIA; PERIORBITAL EDEMA; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; TISSUE SECTION;

ALBUMINS; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CREATININE; DIAGNOSIS, DIFFERENTIAL; DIPHOSPHONATES; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOGLOBULIN G; INCLUSION BODIES; KIDNEY; KIDNEY FAILURE, ACUTE; MIDDLE AGED; MULTIPLE MYELOMA; NEPHROTIC SYNDROME; PODOCYTES; PROTEINURIA;

EID: 31544449161     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000144     Document Type: Article

References (20)

1. Blade J, Fernandez-Llama P, Bosch F et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 1998; 158: 1889-1893.
2. Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc 1975; 50: 29-40.
3. Markowitz GS, Appel GB, Fine PL et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 2001; 12: 1164-1172.
4. Barri YM, Munshi NC, Sukumalchantra S et al. Podocyte injury associated glomerulopathies induced by pamidronate. Kidney Int 2004; 65: 634-641.
5. Markowitz GS, Fine PL, Stack JI et al. Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 2003; 64: 281-289.
6. Markowitz GS, Fine PL, D'Agati VD. Nephrotic syndrome after treatment with pamidronate. Am J Kidney Dis 2002; 39: 1118-1122.
7. Kunin M, Kopolovic J, Avigdor A, Holtzman EJ. Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient. Nephrol Dial Transplant 2004; 19: 723-726.
8. Desikan R, Veksler Y, Raza S et al. Nephrotic proteinuria associated with high dose pamidronate in multiple myeloma. Br J Haematol 2002; 119: 496-499.
9. Lockridge L, Papac RJ, Perazella MA. Pamidronate-associated nephrotoxicity in a patient with Langerhans' histiocytosis. Am J Kidney Dis 2002; 40: E2.
10. Buysschaert M, Cosyns JP, Barreto L, Jadoul M. Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidism. Nephrol Dial Transplant 2003; 18: 826-829.
11. Janssen van Doorn K, Neyns B, Van der Niepen P, Verbeelen D. Pamidronate-related nephrotoxicity (tubulointerstitial nephritis) in a patient with osteolytic bone metastases. Nephron 2001; 89: 467-468.
12. Leboulleux M, Lelongt B, Mougenot B et al. Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies. Kidney Int 1995; 48: 72-79.
13. Messiaen T, Deret S, Mougenot B et al. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore) 2000; 79: 135-154.
14. Carstens PH, Woo D. Crystalline glomerular inclusions in multiple myeloma. Am J Kidney Dis 1989; 14: 56-60.
15. Yamamoto T, Hishida A, Honda N et al. Crystal-storing histiocytosis and crystalline tissue deposition in multiple myeloma. Arch Pathol Lab Med 1991; 115: 351-354.
16. Matsuyama N, Joh K, Yamaguchi Y et al. Crystalline inclusions in the glomerular podocytes in a patient with benign monoclonal gammopathy and focal segmental glomerulosclerosis. Am J Kidney Dis 1994; 23: 859-865.
17. Kowalewska J, Tomford RC, Alpers CE. Crystals in podocytes: an unusual manifestation of systemic disease. Am J Kidney Dis 2003; 42: 605-611.
18. Papla B, Spolnik P, Rzenno E et al. Generalized crystal-storing histiocytosis as a presentation of multiple myeloma: a case with a possible pro-aggregation defect in the immunoglobulin heavy chain. Virchows Arch 2004; 445: 83-89.
19. Tomioka M, Ueki K, Nakahashi H et al. Widespread crystalline inclusions affecting podocytes, tubular cells and interstitial histiocytes in the myeloma kidney. Clin Nephrol 2004; 62: 229-233.
20. Keller LS, Faull RJ, Smith P et al. Crystalloid deposits in the kidney. Nephrology (Carlton) 2005; 10: 81-83.